4//SEC Filing
Meredith Ian T 4
Accession 0001225208-22-002675
CIK 0000885725other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:21 PM ET
Size
12.8 KB
Accession
0001225208-22-002675
Insider Transaction Report
Form 4
Meredith Ian T
EVP/ Global Chief Medical Offi
Transactions
- Tax Payment
Common Stock
2022-02-15$44.01/sh−326$14,347→ 31,621 total - Award
Restricted Stock Units
2022-02-16+4,525→ 4,525 totalExp: 2026-02-16→ Common Stock (4,525 underlying) - Award
Stock Option (Right to Buy)
2022-02-16+12,941→ 12,941 totalExercise: $44.19Exp: 2032-02-16→ Common Stock (12,941 underlying) - Exercise/Conversion
Common Stock
2022-02-15+1,108→ 31,947 total - Exercise/Conversion
Deferred Stock Units
2022-02-15−1,108→ 1,108 totalExp: 2023-02-15→ Common Stock (1,108 underlying)
Footnotes (5)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
- [F3]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
- [F5]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001693920
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 8:21 PM ET
- Size
- 12.8 KB